NCT00908271 Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00904176 Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00859898 Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00855166 Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00842556 Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00839683 Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00831779 Effects of Dapagliflozin on Insulin Resistance and Insulin Secretion in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00736879 Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00680745 Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients Status COMPLETED Phase PHASE3
NCT00673231 Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin Status COMPLETED Phase PHASE3
NCT00663260 Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment Status COMPLETED Phase PHASE2/PHASE3
NCT00660907 Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients Status COMPLETED Phase PHASE3
NCT00643851 An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets Status COMPLETED Phase PHASE3
NCT00562250 Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects Status COMPLETED Phase PHASE1